Importance of the TIMI frame count: implications for future trials

por Appleby, Mark A, Michaels, Andrew D, Chen, Michael, Michael, C Gibson
Publicado 2000

CD4(+) regulatory T cells require CTLA-4 for the maintenance of systemic tolerance

por Friedline, Randall H., Brown, David S., Nguyen, Hai, Kornfeld, Hardy, Lee, JinHee, Zhang, Yi, Appleby, Mark, Der, Sandy D., Kang, Joonsoo, Chambers, Cynthia A.
Publicado 2009

CD4(+) regulatory T cells require CTLA-4 for the maintenance of systemic tolerance

por Friedline, Randall H., Brown, David S., Nguyen, Hai, Kornfeld, Hardy, Lee, JinHee, Zhang, Yi, Appleby, Mark, Der, Sandy D., Kang, Joonsoo, Chambers, Cynthia A.
Publicado 2009

Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis

por Henderson, Robert D., Agosti, Jan M., McCombe, Pamela A., Thorpe, Kathryn, Heggie, Susan, Heshmat, Saman, Appleby, Mark W., Ziegelaar, Brian W., Crowe, David T., Redlich, Garry L.
Publicado 2021

A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity

por Park, Heon, Staehling-Hampton, Karen, Appleby, Mark W., Brunkow, Mary E., Habib, Tania, Zhang, Yi, Ramsdell, Fred, Liggitt, H. Denny, Freie, Brian, Tsang, Mark, Carlson, George, Friend, Sherree, Frevert, Charles, Iritani, Brian M.
Publicado 2008